Walker & Dunlop Inc SEC Filings

Walker & Dunlop, Inc. officer EVP & Chief Operating Officer reported an equity-related transaction on 12/05/2025. The Form 4 shows the acquisition of 94.636 dividend equivalent rights, which the company states are economically equivalent to the same number of shares of its common stock.

The dividend equivalent rights were credited on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. After this transaction, the reporting person beneficially owned 1,292.685 dividend equivalent rights, held directly.

Walker & Dunlop, Inc. executive vice president and Chief HR Officer reported a routine equity-related transaction. On 12/05/2025, the officer acquired 19.75 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units already held by the officer and will vest proportionately with those restricted stock units.

After this transaction, the officer beneficially owned 65.657 derivative securities tied to Walker & Dunlop common stock. The dividend equivalent rights were acquired at a stated price of $0, reflecting their nature as an adjustment linked to existing restricted stock unit awards rather than an open-market purchase.

Walker & Dunlop executive reports dividend equivalent rights

Walker & Dunlop, Inc. executive officer EVP, GC, Secretary & CCO filed a Form 4 reporting an equity-related transaction on 12/05/2025. The filing shows an acquisition (code "A") of 42.837 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock, at a price of $0 per right.

The dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this transaction, the executive beneficially owns 169.545 derivative securities of this type in direct ownership form.

Walker & Dunlop, Inc. executive vice president and chief financial officer reported an equity-related transaction involving derivative securities tied to the company’s common stock. On 12/05/2025, the officer acquired 24.451 dividend equivalent rights, each economically equivalent to one share of common stock, at a price of $0.

These dividend equivalent rights accrued on restricted stock units already held and will vest proportionately with those units over time. Following this transaction, the officer beneficially owned 99.938 derivative securities directly, reflecting ongoing alignment of compensation with the company’s equity performance rather than an open-market purchase or sale.

Walker & Dunlop (WD) filed its Q3 2025 10‑Q, reporting total revenues of $337.7 million, up from $292.3 million a year ago. Net income was $33.5 million versus $28.8 million, with diluted EPS of $0.98 compared to $0.85. For the nine months, revenues reached $894.3 million and net income was $70.2 million.

Growth was broad-based: loan origination and debt brokerage fees were $97.8 million, servicing fees were $85.2 million, property sales broker fees were $26.5 million, and fair value of expected net cash flows from servicing added $48.7 million. MSRs carried a net value of $806.0 million after $52.3 million of quarterly amortization. The at-risk Fannie Mae servicing portfolio CECL allowance was $24.8 million with a forecast-period loss rate of 2.1 basis points in Q3.

Total assets were $5.80 billion (up from $4.38 billion at year-end), driven by loans held for sale of $2.20 billion. Warehouse notes payable increased to $2.18 billion. Servicing UPB was $139.3 billion. The company maintained $6.05 billion of Agency warehouse capacity with $2.18 billion outstanding, and had a $450 million term loan (balance $447.8 million) plus $400 million of Senior Notes hedged via a fair value swap tied to SOFR. Allowance for risk‑sharing obligations was $34.1 million.

Walker & Dunlop, Inc. amended its Master Repurchase Agreement with JPMorgan Chase Bank, N.A., extending the agreement's Termination Date to September 10, 2026. The company continues to guarantee the operating subsidiary Walker & Dunlop, LLC's obligations under the repurchase facility. A Side Letter dated September 11, 2025 updates fees, commitments and pricing, temporarily increasing the defined Facility Amount to $1,500,000,000 from September 11, 2025 through November 20, 2025, after which the Facility Amount will revert to $1,000,000,000 (previously $950,000,000). The Side Letter also revises the Non-Usage Fee definition and eliminates the Upfront Fee.

Walker & Dunlop director Ernest Michael Freedman was granted 1,097 shares of restricted common stock on 09/11/2025 under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan. The award was issued at no cash cost ($0 per share) and is reported as direct ownership of 1,097 shares following the grant. The restricted shares vest on May 1, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/15/2025.

Ernest Michael Freedman, identified as a director of Walker & Dunlop, Inc. (WD), submitted an initial Form 3 reporting that he does not beneficially own any securities of the issuer. The filing lists a company address and notes Exhibit 24 (Power of Attorney) was furnished and the form was executed by an attorney-in-fact. This is a routine Section 16 disclosure establishing the reporting obligation and confirming no direct or indirect holdings were reported.